Categories: News

BioCorRx Featured on LiveNOW from FOX

ANAHEIM, CA, June 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Tom Welch, Executive Vice President of BioCorRx Inc., was featured on LiveNOW from FOX. Mr. Welch discussed BioCorRx’s pilot program with 2B3D, a virtual, augmented, and mixed reality technology company, a first-of-its-kind post-traumatic stress disorder (PTSD) and addiction treatment solutions program for veterans in the metaverse setting.

LiveNOW from FOX is a non-stop stream of breaking news, live events and stories taking place across the nation.

To watch the interview, please go to: https://www.biocorrx.com/news-media/media.

About BioCorRx

BioCorRx Inc. (OTCQB: BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. Beat Addiction Recovery is a substance use disorder recovery program that typically includes BioCorRx’s proprietary Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx® Weight Loss Program is also a medication assisted weight loss program that includes access to concierge on-demand wellness specialists: nutritionists, fitness experts and personal support from behavioral experts; please visit www.uncraverx.com for more information on UnCraveRx®. The Company also controls BioCorRx Pharmaceuticals, a clinical stage drug development subsidiary currently seeking FDA approval for BICX104, an implantable naltrexone pellet for treatment of alcohol and opioid use disorders. For more information on BICX and its subsidiary pipeline, please visit www.BioCorRx.com.

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown. risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

BioCorRx Inc.
investors@BioCorRx.com
714-462-4880

Investor Relations:
Crescendo Communications, LLC
(212) 671-1020 x304
bicx@crescendo-ir.com

Media Contact:
PhillComm Global
BioCorRx@PhillComm.Global
704.942.1557

Staff

Recent Posts

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

5 hours ago

Laboratory Services Cooperative Notifies Individuals of Security Incident

SEATTLE, April 10, 2025 /PRNewswire/ -- Laboratory Services Cooperative (LSC), a non-profit organization based in…

5 hours ago

True Dental Care Provides Notice of Data Incident

SUWANEE, Ga., April 10, 2025 /PRNewswire/ -- On February 3, 2025, True Dental Care ("True…

5 hours ago

Groundbreaking Study Explores THC Beverages as a Wellness Alternative to Alcohol

PHILADELPHIA, April 10, 2025 /PRNewswire/ -- MoreBetter, a leader in Real-World-Data collection and research, has…

5 hours ago

Launch and Learn: Media Invited to Science Webinar on NASA’s SpaceX CRS-32 Mission

Register today for the April 16 webinar, featuring cutting-edge biotech, plant biology, and airborne pollutant…

5 hours ago

Global Pharma Organization Implements Advanced Signals as Part of LifeSphere Safety Platform

BOSTON, April 10, 2025 /PRNewswire/ -- ArisGlobal, an innovative technology company at the forefront of life…

11 hours ago